Gold futures were up 1.5%, to about $1,317 per ounce as investors sought safety in so-called hard assets.
The VIX (VIX), which measures volatility and is sometimes dubbed the "Fear Gauge", shot up as much as 17% following a report by a Russian news service that a Malaysian Airlines flight from Amsterdam to Kuala Lumpur had crashed in eastern Ukraine.
CNNMoney's Fear & Greed index, which is based on the VIX and other measures of investor sentiment, fell several points too. It's currently in neutral mode. A month ago, the index was indicating extreme greed was driving the market.
Malaysian Airlines confirmed on Twitter that it had lost contact with flight MH17, and the plane's last known position was over Ukrainian airspace. The plane was carrying 295 passengers.
Best Prefered Stocks To Own Right Now: Sealed Air Corporation(SEE)
Sealed Air Corporation, through its subsidiaries, provides food safety and security, facility hygiene, and product protection solutions worldwide. Its Food Packaging segment provides shrink bags and vacuum packaging products; packaging materials for cook-in applications; laminated and coextruded rollstock packaging materials used in thermoforming and form, fill, and seal applications; and associated packaging equipment and systems, including bag loaders, dispensers, and vacuum chamber systems. The company?s Food Solutions segment offers case-ready packaging offerings; ready meals packaging technologies; vertical pouch packaging solutions for packaging flowable food products; foam and plastic trays; absorbent products for food packaging; and related packaging equipment, including vacuum chamber systems. Its Protective Packaging segment provides air cellular packaging materials; polyolefin performance shrink films for product display; shrink packaging equipment systems; pol yurethane foam packaging systems that provide protective packaging; lightweight and tear-resistant mailers and bags; inflatable packaging systems; paper cushioning systems that include recycled paper and automated dispensing equipment; paper packaging products; and suspension and retention packaging products. The company?s Diversey Segment offers a range of products and services, such as kitchen cleaning products; food and beverage and manufacturing and processing products; floor care products and systems; restroom care and other housekeeping products; and laundry products, as well as consulting services. Sealed Air Corporation also provides specialty materials products to fabricators and manufacturers; and medical applications products and solutions to medical device manufacturers and pharmaceutical companies. The company markets its products primarily under the Bubble Wrap, Cryovac, and Diversey brands. Sealed Air Corporation was founded in 1960 and is headquartered in El mwood Park, New Jersey.
Advisors' Opinion:- [By Lee Jackson]
Basic Materials: Sealed Air Corp. (NYSE: SEE) is top pick at other firms that we cover on Wall Street as well. Credit Suisse believes that following the recent (October) management change at the company, Sealed Air will significantly improve its profitability and cash flows while also deleveraging its sizable debt load, with both of these things driving significant shareholder value. The price target for the stock is posted at $36. The Thomson/First Call estimate is at $33. Investors are paid a 1.9% dividend. Credit Suisse is the high target on Wall Street and would represent a 31% gain for investors. The stock closed Tuesday at $27.48.
- [By Tom Rojas and Maria Armental var popups = dojo.query(".socialByline .popC"); ]
Sealed Air Corp.'s(SEE) third-quarter earnings topped consensus estimates and it again raised its 2014 bottom-line guidance as the packaging company benefits from higher prices.
Best Companies To Invest In 2014: Endeavour International Corp (END)
Endeavour International Corporation (Endeavour), incorporated on January 13, 2000, is an independent oil and gas company engaged in the exploration, development and acquisition of energy reserves in the United States and United Kingdom. The Company has three producing fields in the United Kingdom, including Alba, Bacchus and Bittern, as well as a number of development projects including Rochelle and Columbus. In the United States, the Company has production in the Haynesville and Marcellus, as well as two oil frontier plays in Colorado and Montana. As of December 31, 2012, Endeavour had proved reserves of 71,591 million cubic feet (MMcf) of natural gas and 13,739 thousands of barrels (Mbbls) of crude oil for a combined 25.7 million barrels of oil equivalent (MBOE).
The North Sea is a resource area where it has a development project, producing properties and additional exploration licenses. During 2012, Alba production volumes were impacted by water handling issues. As of December 31, 2012, it held a 30% working interest in its Bacchus field asset, which is operated by Apache Corporation, who owns a 50% working interest. In April and July 2012, it achieved production from the first and second development wells, respectively, on the Bacchus field. The Company�� working interest in the Rochelle area is 44% and it is the operator of the field, which is comprised of Blocks 15/26b, 15/26c and 15/27. Its United States activity has targeted reserve and production growth in shale gas plays, including the Louisiana Haynesville and Pennsylvania Marcellus areas.
The Company is also targeting emerging oil-prone and liquids-rich plays, including the Montana Heath oil play and its new interests in the Colorado Niobrara area. The Company operates and controls the Marcellus assets while retaining a 50% position in its remaining producing Haynesville acreage. The Company has 19 Haynesville Units which held by production with an estimated over 80 remaining gross locations to be developed, dep! ending on development well spacing. The Company has interests in approximately 88,900 net acres in the emerging Heath Shale oil play in Montana, primarily in Rosebud and Garfield Counties.
Advisors' Opinion:- [By Jake L'Ecuyer]
Energy shares dropped by 0.26 percent in the US market today. Among the sector stocks, Endeavour International (NYSE: END) was down more than 5.6 percent, while Pacific Ethanol (NASDAQ: PEIX) tumbled around 2.2 percent.
- [By Jake L'Ecuyer]
Leading and Lagging Sectors
Wednesday morning, the financial sector proved to be a source of strength for the market. Leading the sector was strength from SouFun Holdings (NYSE: SFUN) and E-House (China) Holdings (NYSE: EJ). In trading on Wednesday, energy shares were relative laggards, down on the day by about 0.67 percent. Among the energy stocks, Endeavour International (NYSE: END)was down more than 22 percent, while TransGlobe Energy (NASDAQ: TGA) tumbled around 6 percent. - [By Jon C. Ogg]
Endeavour International Corp. (NYSE: END) was downgraded to Hold from Buy at Canaccord Genuity.
Endo Health Solutions Inc. (NASDAQ: ENDP) was downgraded to Sell from an already cautious Neutral rating at Janney.
- [By Paul Ausick]
Stocks on the Move: Alcoa Inc. (NYSE: AA) is up 9.1% at $9.38 after posting a new 52-week high of $9.63 earlier today. Endeavour International Corp. (NYSE: END) is down 14.3% at $6.05 after failing to get any appreciable results from its strategic review. E-commerce China Dangdang Inc. (NYSE: DANG) is down 13.4% at $10.05 after issuing a warning on third-quarter earnings.
Best Companies To Invest In 2014: Equifax Inc. (EFX)
Equifax Inc. collects, organizes, and manages various financial, demographic, employment, and marketing information solutions for businesses and consumers. The company�s U.S. Consumer Information Solutions segment provides consumer information services, such as credit information, credit scoring, credit modeling, locate, fraud detection and prevention, identity verification, and other consulting services; mortgage loan origination information, appraisal, title, and closing services; consumer financial marketing services; and identity management services. Its International segment provides information services products, which include consumer and commercial services, such as credit and financial information, and credit scoring and modeling services; and credit and other marketing products and services. The company�s Workforce Solutions segment offers employment, income, and social security number verification services, as well as employment tax and talent management servi ces. Its North America Personal Solutions segment sells credit information, credit monitoring, and identity theft protection products directly to consumers through the Internet and hard-copy formats. The company�s North America Commercial Solutions segment offers commercial products and services comprising business credit and demographic information, credit scores, and portfolio analytics, which are derived from its databases of business credit, financial, and demographic information. It serves customers in financial services, mortgage, human resources, consumer, commercial, telecommunications, retail, automotive, utilities, brokerage, healthcare, and insurance industries; and state and federal governments. The company has operations in Argentina, Canada, Chile, Costa Rica, Ecuador, El Salvador, Honduras, Paraguay, Peru, Portugal, Spain, the United Kingdom, Uruguay, the United States, and the Republic of Ireland. Equifax Inc. was founded in 1899 and is headquartered in Atla nta, Georgia.
Advisors' Opinion:- [By WWW.DAILYFINANCE.COM]
Jupiterimages.com When it comes to understanding your credit, it can feel as complicated as trying to solve a Rubik's cube. Frustrated by this confusion, many consumers neglect their credit, which can have a devastating impact on their financial futures. A Consumer Action study recently revealed that 27 percent of Americans have never checked their credit report. That's alarming, because it's estimated that a large numbers of consumers have errors on their credit reports that could damage their credit. I found this out several years ago when I found an error -- a canceled account that was being reported as delinquent -- hurting my credit. In my research, I have identified three sneaky things that are hurting other people's credit, too. Surprisingly, they could be fixed in 15 minutes or less. First, you need to get your credit report, and you should go to AnnualCreditReport.com. From this site, you can request your free credit report once a year from the three major credit reporting agencies -- (Equifax (EFX), Experian (EXPGY) and TransUnion). You can also access your credit score there, but you'll have to pay a small fee. To get a free credit score, you can go to Credit.com or Creditkarma.com. Keep in mind that these two as well as a lot of other free sites offer a consumer education score, which isn't your actual FICO (FICO) score. This confused even me when I sought to find my real credit score. Your FICO score changes daily, so getting your credit scores from these free sites will give you a good gauge of approximately what your credit score is. 1. Wrong Information The wrong personal information on your credit report could hurt your credit. This could be things like your name, your home address, where you've worked in the past or even your Social Security number. How does a wrong address hurt your credit? Your information may be mixed up with someone else's, especially if you have a common name, or are a "Jr." or "Sr." Or it could indicate identity th
- [By U.S. News]
Alamy Everyone makes mistakes and credit bureaus are no exception. In fact, a Federal Trade Commission study last year found that one in four consumer credit reports contain errors -- these include everything from minor mistakes to outrageous oversights. It's important to know what to look for when you're checking for mistakes in your credit reports. There are three types: identity errors, incorrect account details and fraudulent accounts. 1. Identity errors. The three major credit bureaus are Equifax (EFX), Experian and TransUnion. Each bureau maintains its own database of consumer data, including personal information, account information and payment history. This information is included in your credit reports. From time to time, a credit bureau -- or all three -- will get some information wrong. Some of these errors are minor. For instance, one bureau might have your street address incorrect. It's annoying, but it won't hurt your credit. Other times, it's a more serious error: Your name could become mixed up with someone else's, and you could begin seeing some of his accounts on your credit report. This will affect your credit either positively or negatively, depending on his payment history. 2. Incorrect account details. Sometimes the bank or lender providing information about your accounts to the credit bureaus gets things wrong. On the other hand, the credit bureau could incorrectly process the information provided. For instance, your credit card could be displaying the wrong credit limit, your mortgage might have the incorrect origination date or your auto loan could show as "open" when it's clearly been closed. 3. Fraudulent accounts. This is the most serious error out there, since it means someone has used your identity -- including your name, Social Security number and other personal data -- to open and begin using an account. If there's a line of credit on your credit report that you didn't open, you'll want to move quickly to ensure that th
Best Companies To Invest In 2014: AbbVie Inc (ABBV)
AbbVie Inc. (AbbVie), incorporated on April 10, 2012, is a research-based pharmaceuticals company. The Company discovers, develops, and commercializes advanced therapies. AbbVie's portfolio of products include a line of adult and pediatric pharmaceuticals, which includes HUMIRA, metabolics/hormones products, virology products, endocrinology products, dyslipidemia products and other products.
AbbVie products are used to treat rheumatoid arthritis, psoriasis, Crohn's disease, human immunodeficiency virus (HIV), cystic fibrosis complications, low testosterone, thyroid disease, Parkinson's disease and complications associated with chronic kidney disease, among other indications. In October 2012, AbbVie initiated a comprehensive Phase III program for hepatitis C virus (HCV) genotype one.
Advisors' Opinion:- [By Keith Speights]
There have been some concerns that apremilast wouldn't be able to effectively compete against the "big boys" of rheumatology -- including AbbVie's (NYSE: ABBV ) Humira, Amgen's (NASDAQ: AMGN ) Enbrel, and Johnson & Johnson's (NYSE: JNJ ) Remicade. AbbVie raked in nearly $9.3 billion in sales for Humira last year. Enbrel made $4.2 billion for Amgen and another $3.7 billion for its partner, Pfizer.�J&J reported $6.1 billion in 2012 revenue from Remicade. Its marketing partner, Merck, also made a little over $2 billion from the drug.� Could newcomer apremilast really make inroads against these giants?
- [By Tom Rojas var popups = dojo.query(".socialByline .popC"); popups.forEach(func]
AbbVie Inc.(ABBV) and Shire (SHPG) PLC officially agreed Monday to terminate their $54 billion deal, killing the year’s biggest agreed-upon merger.
Best Companies To Invest In 2014: (AUQ)
AuRico Gold Inc. engages in the exploration, development, and production of gold and silver projects and properties in Canada, Mexico, and Australia. Its principal property includes the Ocampo mine covering approximately 15,000 hectares located in Chihuahua State. The company was formerly known as Gammon Gold Inc. and changed its name to AuRico Gold Inc. in June 2011. AuRico Gold Inc. was founded in 1986 and is based in Toronto, Canada.
Advisors' Opinion:- [By Rich Duprey]
Gold miner�AuRico Gold (NYSE: AUQ ) announced today�its second-quarter dividend of $0.04 per share, the second dividend payment it's made since initiating the program earlier this year.�The board of directors said the quarterly dividend is payable on July 29 to the holders of record at the close of business on July 15.�
- [By Garrett Cook]
In trading on Tuesday, basic materials shares were relative leaders, up on the day by about 0.02 percent. Top gainers in the sector included AuRico Gold (NYSE: AUQ), up 4.9 percent, and CF Industries Holdings (NYSE: CF), up 6.5 percent.
Best Companies To Invest In 2014: Abbott Laboratories(ABT)
Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products worldwide. The company offers adult and pediatric pharmaceuticals for rheumatoid and psoriatic arthritis, ankylosing spondylitis, psoriasis, and Crohn's disease; dyslipidemia; HIV infection; prostate cancer, endometriosis and central precocious puberty, and anemia caused by uterine fibroids; respiratory syncytial virus; adult males who have low or no testosterone; secondary hyperparathyroidism; hypothyroidism; and pancreatic exocrine insufficiency, as well as anesthesia products. It also provides diagnostic products, such as immunoassay systems; chemistry systems; assays used for screening and/or diagnosis for drugs of abuse, cancer, therapeutic drug monitoring, fertility, physiological, and infectious diseases; instruments that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infections agents; genomic-b ased tests; hematology systems and reagents; and point-of-care diagnostic systems and tests for blood analysis. In addition, the company offers a line of pediatric and adult nutritional products. Further, it provides coronary, endovascular, vessel closure, and structural heart devices, such as drug-eluting stent systems, coronary metallic stents, balloon dilatation products, coronary guidewires, vessel closure devices, carotid stent systems, percutaneous valve repair systems, and drug eluting bioresorbable vascular products. Additionally, the company provides blood glucose monitoring meters, test strips, data management software, and accessories for people with diabetes; and medical devices for the eye, including cataract surgery, lasik surgery, contact lens, and dry eye products, as well as branded generic pharmaceutical products. Abbott primarily serves retailers, wholesalers, hospitals, and health care facilities. Abbott was founded in 1888 and is headquartered in Abbott Park, Illinois.
Advisors' Opinion:- [By Keith Speights]
Investors looking to find out how well Abbott Labs (NYSE: ABT ) performed in the second quarter had reason to be confused this morning. One headline stated that "Abbott's quarterly profit rises" while another said that the company's "second-quarter profit falls." Which headline was correct? Actually, both were. Let's look at Abbott's financial results to find out how and why.
- [By Victor Selva]
As we can see, the firm has a lower ROE than Abbott Laboratories (ABT), Thermo Fisher Scientific Inc. (TMO) and CVS Caremark Corporation (CVS).
Final Comment
- [By Brendan Conway]
The intuition is something like this: You��e investing in quality companies with strong balance sheets which are capable of weathering rough markets. But they��e not stodgy old dividend-centric companies so much as growing firms which choose dividends as a means of rewarding shareholders, such as Abbott Laboratories (ABT) or Lowe’s (LOW).
- [By Brian Pacampara]
Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, health care giant Abbott Laboratories (NYSE: ABT ) has earned a coveted five-star ranking.
No comments:
Post a Comment